|
Oct 1
|
Is Immunovant, Inc. (IMVT) the Worst Performing Stock to Buy on the Dip?
|
|
Sep 30
|
Is Roivant Sciences Ltd. (NASDAQ:ROIV) The Best NASDAQ Stock Under $50 To Buy?
|
|
Sep 9
|
What's Going In With Vivek Ramaswamy-Founded Roivant Sciences Stock On Monday?
|
|
Sep 9
|
Immunovant touts positive Phase II batoclimab data as IMVT-1402 also progresses
|
|
Sep 9
|
IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab
|
|
Sep 9
|
Roivant Provides Update on Graves’ Disease Development Program
|
|
Sep 9
|
Immunovant Provides Update on Graves’ Disease Development Program
|
|
Jul 23
|
We Think Immunovant (NASDAQ:IMVT) Can Afford To Drive Business Growth
|
|
May 13
|
Wall Street Analysts Think Immunovant (IMVT) Could Surge 68.63%: Read This Before Placing a Bet
|
|
May 7
|
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
|
|
May 6
|
5 Biotech Stocks Worth Adding to Your Portfolio in 2024
|
|
Apr 24
|
Should You Hold Immunovant (IMVT)?
|
|
Apr 22
|
Here's Why You Should Add Immunovant (IMVT) to Your Portfolio
|
|
Apr 17
|
What Makes Immunovant (IMVT) a New Buy Stock
|
|
Mar 25
|
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
|
|
Mar 21
|
Argenx, Immunovant Soar — As Tourmaline Plummets — On A Rival's Lackluster Test Results
|
|
Mar 17
|
11 Oversold Biotech Stocks To Buy Right Now
|
|
Mar 14
|
10 Stocks George Soros and Insiders Are Crazy About
|
|
Mar 13
|
Why Is Immunovant, Inc. (IMVT) Down 14.7% Since Last Earnings Report?
|
|
Mar 12
|
Immunovant Awarded U.S. Patent for IMVT-1402
|